Search clinical trials for: Fentanyl Transdermal Therapeutic System (TTS)

Total 1878 results

Janssen-Cilag Ltd.

Completed

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Cancer, Pain
Alza Corporation, DE, USA

Completed

Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

Pain | Cancer
Alza Corporation, DE, USA

Completed

Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

Pain | Cancer
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy

Chronic Pain
Janssen Pharmaceutica N.V., Belgium

Completed

A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy

Chronic Pain
South Egypt Cancer Institute

Unknown

Efficacy of Transdermal Fentanyl Patches in Relief of Acute Postoperative Pain After Mastectomy

Breast Cancer Female

Egypt
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants

Healthy

United States
Johnson & Johnson Taiwan Ltd

Completed

Fentanyl for Treatment Pain Caused by Radiotherapy

Pain
University of Maryland, Baltimore
Food and Drug Administration (FDA)

Completed

Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl TDSs in Healthy Adults

Peer Review, Research

United States
Janssen Pharmaceutical K.K.

Completed

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Pain | Cancer

Japan
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers

Healthy

Belgium
Alza Corporation, DE, USA

Withdrawn

An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients

Pain, Postoperative | Pediatrics
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use Disorders (CTN-0044)

Substance Abuse

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

CPT for Offenders With SUD (CPT)

Computer-assisted, Evidence-based Psychosocial Intervention | for Substance Abuse Treatment

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Pain | Cancer

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

Pain

United States
Janssen Korea, Ltd., Korea

Completed

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

Chronic Pain

Korea, Republic of
Mylan Pharmaceuticals Inc

Terminated

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

Healthy

United States
Janssen-Cilag G.m.b.H

Terminated

A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain

Postoperative Pain

Germany
Actavis Inc.

Completed

A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System

Healthy

Canada
Mylan Pharmaceuticals Inc

Completed

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

Healthy

United States
ZARS Pharma Inc.

Completed

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Pain

United States
Johns Hopkins University
PriCara, Unit of Ortho-McNeil, Inc.

Completed

Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain

Peripheral Neuropathy | Complex Regional Pain Syndromes (CRPS)
Janssen-Cilag Ltd.,Thailand

Completed

Efficacy and Safety Study of Transdermal Therapeutic System (TTS) Fentanyl in Participants With Osteoarthritis Knee Pain

Osteoarthritis, Knee

Thailand
Janssen-Cilag Ltd.,Thailand

Completed

An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Participants With Osteoarthritis

Osteoarthritis

Thailand
Janssen-Cilag Ltd.,Thailand

Completed

An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Severe Chronic Low Back Pain

Low Back Pain

Thailand
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis

Arthritis | Osteoarthritis | Rheumatoid Arthritis
Chongqing University Cancer Hospital

Completed

Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients

Nutrition Disorders | Cancer Pain

China
Cristália Produtos Químicos Farmacêuticos Ltda.

Withdrawn

Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)

Pain | Palliative Care

Brazil
Medical University of Graz

Completed

Traumatologic Acute Pain Management With Fentanyl Transdermal Therapeutic System (TTS)

Hip Fractures (ICD-10 72.01-72.2)

Austria
Ente Ospedaliero Cantonale, Bellinzona

Not yet recruiting

Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery (MoFe)

Obstetric Pain
Baskent University

Completed

Fentanyl 12 Mcg Transdermal Patch For Postoperative Pain

Postoperative Pain
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

Chronic Pain
Janssen-Cilag Ltd.,Thailand

Completed

An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant Pain

Chronic Pain

Thailand
Akela Pharma, Inc.

Unknown

Safety of Fentanyl TAIFUN Treatment (FINDS)

Breakthrough Cancer Pain

Poland
Guided Therapy Systems
University of Arizona

Completed

Intense Therapeutic Ultrasound - Treatment for Chronic Plantar Fascia Musculoskeletal Pain Reduction (ITU)

Chronic Plantar Fasciitis

United States
Guided Therapy Systems
More Foundation

Completed

ITU Treatment for Chronic Epicondylitis Musculoskeletal Pain Reduction (ITU)

Tennis Elbow

United States
Khon Kaen University

Completed

Study of Transdermal Fentanyl Patch to Treat Postoperative Pain in Total Knee Arthroplasty (TFP)

Postoperative Pain

Thailand
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Totally Transdermal Sedation in the Weaning From Remifentanil Infusion (TOES)

Respiratory Insufficiency | Ventilator Weaning | Analgesics, Opioid

Italy
Janssen-Cilag, S.A.

Completed

A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).

Pain
University Foot and Ankle Foundation
Guided Therapy Systems

Completed

Intense Therapeutic Ultrasound for the Treatment of Chronic Plantar Fasciitis (ITU)

Plantar Fasciitis, Chronic
Preceptis Medical, Inc.

Completed

In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old

Otitis Media | Ear Infection

United States
Khon Kaen University

Completed

Transdermal Fentanyl Patch for Postoperative Analgesia After Abdominal Surgery: a Randomized Placebo-controlled Trial

Postoperative Pain Relief

Thailand
Durect

Completed

Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia

Pain | Postherpetic Neuralgia

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Pain

United States
Fujian Cancer Hospital

Unknown

Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive
Alza Corporation, DE, USA

Terminated

A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)

Pain

Germany, Austria, Finland, Netherlands
424 General Military Hospital
Aristotle University Of Thessaloniki

Recruiting

Nitrate Use to Obtain Radial Spasm Embarrassment (NURSE - TTS Trial) (NURSE-TTS)

Radial Artery Spasm

Greece

3

Subscribe